Inflammation from leaking mitochondria drives aggressive pancreatic cancer growth
Summary
Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential therapy.
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.